Investors were reassured by some positive news about the Omicron variant, which had helped them flee the risk last week.
Before the market was opened, the British pharmaceutical company GSK announced that an antibody-based therapy against Covid-19 that it is developing with Vir Biotechnology was effective against all mutations in the new strain.
For his part, the renowned American infectologist Anthony Fauci remarked that preliminary tests indicate that, although Ómicron probably has a higher degree of transmissibility, it appears to be less serious.
In parallel, Intel’s announcement of plans to list its Mobileye self-driving vehicle unit next year sent its shares soaring and encouraged chip investors.
The Philadelphia Semiconductor Index at one point rose more than 5% after hitting a nearly a month low on Tuesday.
In this context, the CBOE volatility index also fell from the high of more than 10 months that it reached last week.